Skip to Content

Align Technology Inc

ALGN: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$615.00VmlvxwPlmydvvf

Align Earnings: Crooked Third-Quarter Results Leave Investors Frowning, but We Think Shares Are Cheap

Narrow-moat Align Technology reported disappointing third-quarter results and, after adjusting our model, we've lowered our fair value estimate to $316 per share, down from $338. Total sales were up 7.8% year over year, but difficult macroeconomic conditions and weaker consumer sentiment weighed down top and bottom line, both of which missed consensus. Dynamic conditions driven by lower demand, especially from adult patients, loomed over the firm during the quarter and we expect this concern to continue throughout the year. Management, citing reports of deceleration for orthodontic treatment for September, trimmed full-year sales guidance roughly 4% and expects lower operating margin compared with last year.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of ALGN so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center